Dr Reddy's Q4 Preview: Profit To Rise 37% YoY To Rs 413cr

Dr Reddy's Laboratories is slated to come out with its fourth quarter earnings on May 17. Kotak Institutional Equities expects the pharma major to report a net profit of Rs 413.6 crore, up 36.9 percent year-on-year and down 14.8 percent quarter-on-quarter.

Sales are expected to increase 7.7 percent YoY (down 1.1 percent QoQ) to Rs 3,807.5 crore.

Earnings before interest, tax, depreciation and amortisation is likely to rise 42.6 percent YoY (down 3.7 percent QoQ) to Rs 785.5 crore.

The research firm expects the US business to grow $10 million QoQ, given the benefits of Propofol and Suboxone launches, but the same could be offset by continued erosion in Metoprolol sales.

For more information ✆ +91- 6232578593 or visit www.moneymarketmanthan.com